Literature DB >> 11709358

Multidrug resistant Mycobacterium leprae from patients with leprosy.

S Maeda1, M Matsuoka, N Nakata, M Kai, Y Maeda, K Hashimoto, H Kimura, K Kobayashi, Y Kashiwabara.   

Abstract

Sequences of the folP1, rpoB, and gyrA genes were analyzed for 88 isolates of Mycobacterium leprae from leprosy patients in Japan, Haiti, Indonesia, Pakistan, and the Philippines. Thirteen isolates (14.8%) showed representative mutations in more than two genes, suggesting the emergence of multidrug-resistant M. leprae.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11709358      PMCID： PMC90887          DOI： 10.1128/AAC.45.12.3635-3639.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  19 in total

1.  Application of a polymerase chain reaction for the detection of Mycobacterium leprae in skin tissues.

Authors:  M Y de Wit; W R Faber; S R Krieg; J T Douglas; S B Lucas; N Montreewasuwat; S R Pattyn; R Hussain; J M Ponnighaus; R A Hartskeerl
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

2.  Further experience with the kinetic method for the study of drugs against Mycobacterium leprae in mice. Activities of DDS, DFD, ethionamide, capreomycin and PAM 1392.

Authors:  C C Shepard
Journal:  Int J Lepr Other Mycobact Dis       Date:  1969 Oct-Dec

3.  Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis.

Authors:  A Telenti; P Imboden; F Marchesi; D Lowrie; S Cole; M J Colston; L Matter; K Schopfer; T Bodmer
Journal:  Lancet       Date:  1993-03-13       Impact factor: 79.321

4.  Rifampin-resistant leprosy.

Authors:  R R Jacobson; R C Hastings
Journal:  Lancet       Date:  1976-12-11       Impact factor: 79.321

Review 5.  Antimicrobial agent resistance in mycobacteria: molecular genetic insights.

Authors:  J M Musser
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

6.  Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations.

Authors:  H E Takiff; L Salazar; C Guerrero; W Philipp; W M Huang; B Kreiswirth; S T Cole; W R Jacobs; A Telenti
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

7.  Molecular basis of rifampin resistance in Mycobacterium leprae.

Authors:  N Honore; S T Cole
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

8.  Cloning and sequence determination of the gene coding for the elongation factor Tu of Mycobacterium leprae.

Authors:  S Dhandayuthapani; M J Banu; Y Kashiwabara
Journal:  J Biochem       Date:  1994-04       Impact factor: 3.387

9.  Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice.

Authors:  B Ji; E G Perani; C Petinom; J H Grosset
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

10.  Characterization of rifampin-resistance in pathogenic mycobacteria.

Authors:  D L Williams; C Waguespack; K Eisenach; J T Crawford; F Portaels; M Salfinger; C M Nolan; C Abe; V Sticht-Groh; T P Gillis
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191
View more
  46 in total

1.  Real-time PCR and high-resolution melt analysis for rapid detection of Mycobacterium leprae drug resistance mutations and strain types.

Authors:  Wei Li; Masanori Matsuoka; Masanori Kai; Pratibha Thapa; Saraswoti Khadge; Deanna A Hagge; Patrick J Brennan; Varalakshmi Vissa
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

2.  Computational genome analyses of metabolic enzymes in Mycobacterium leprae for drug target identification.

Authors:  Anusuya Shanmugam; Jeyakumar Natarajan
Journal:  Bioinformation       Date:  2010-03-31

3.  Molecular drug susceptibility testing and genotyping of Mycobacterium leprae strains from South America.

Authors:  Pushpendra Singh; Philippe Busso; Alberto Paniz-Mondolfi; Nacarid Aranzazu; Marc Monot; Nadine Honore; Andrea de Faria Fernandes Belone; Marcos Virmond; Maria Esther Villarreal-Olaya; Carlos Rivas; Stewart T Cole
Journal:  Antimicrob Agents Chemother       Date:  2011-03-28       Impact factor: 5.191

Review 4.  Leprosy in the 21st century.

Authors:  Cassandra White; Carlos Franco-Paredes
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

5.  Identification of primary drug resistance to rifampin in Mycobacterium leprae strains from leprosy patients in Amazonas State, Brazil.

Authors:  Matilde Del Carmen Contreras Mejía; Maísa Porto Dos Santos; George Allan Villarouco da Silva; Isabella da Motta Passos; Felipe Gomes Naveca; Maria da Graça Souza Cunha; Milton Ozório Moraes; Lucia de Paula
Journal:  J Clin Microbiol       Date:  2014-10-01       Impact factor: 5.948

6.  Emergence of Mycobacterium leprae Rifampin Resistance Evaluated by Whole-Genome Sequencing after 48 Years of Irregular Treatment.

Authors:  Charlotte Avanzi; Raquel Cristina Maia; Stewart Thomas Cole; Milton Ozório Moraes; Andrej Benjak; José Augusto Nery; Anna Maria Sales; Alice Miranda; Nadia Cristina Duppre; Amanda Nogueira Brum Fontes; Tatiana Pereira da Silva; Roberta Olmo Pinheiro; Fernanda Neves-Manta; Suelen Justo Maria Moreira; Philippe Busso; Euzenir Nunes Sarno; Phillip Noel Suffys
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

7.  Mycobacterial phenolic glycolipid virulence factor biosynthesis: mechanism and small-molecule inhibition of polyketide chain initiation.

Authors:  Julian A Ferreras; Karen L Stirrett; Xuequan Lu; Jae-Sang Ryu; Clifford E Soll; Derek S Tan; Luis E N Quadri
Journal:  Chem Biol       Date:  2007-12-27

8.  Rapid variable-number tandem-repeat genotyping for Mycobacterium leprae clinical specimens.

Authors:  Miyako Kimura; Rama Murthy Sakamuri; Nathan A Groathouse; Becky L Rivoire; David Gingrich; Susan Krueger-Koplin; Sang-Nae Cho; Patrick J Brennan; Varalakshmi Vissa
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

9.  Vaccination with the ML0276 antigen reduces local inflammation but not bacterial burden during experimental Mycobacterium leprae infection.

Authors:  Vanitha S Raman; Joanne O'Donnell; H Remy Bailor; Wakako Goto; Ramanuj Lahiri; Thomas P Gillis; Steven G Reed; Malcolm S Duthie
Journal:  Infect Immun       Date:  2009-09-28       Impact factor: 3.441

10.  Are all the DNA gyrase mutations found in Mycobacterium leprae clinical strains involved in resistance to fluoroquinolones?

Authors:  Stéphanie Matrat; Emmanuelle Cambau; Vincent Jarlier; Alexandra Aubry
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.